2-butyl-2-ethyl-1,3-propanediol
General Information
Mainterm | 2-butyl-2-ethyl-1,3-propanediol |
CAS Reg.No.(or other ID) | 115-84-4 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 61038 |
IUPAC Name | 2-butyl-2-ethylpropane-1,3-diol |
InChI | InChI=1S/C9H20O2/c1-3-5-6-9(4-2,7-10)8-11/h10-11H,3-8H2,1-2H3 |
InChI Key | DSKYSDCYIODJPC-UHFFFAOYSA-N |
Canonical SMILES | CCCCC(CC)(CO)CO |
Molecular Formula | C9H20O2 |
Wikipedia | 2-ethyl-2-butyl-1,3-propanediol |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 160.257 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Complexity | 87.6 |
CACTVS Substructure Key Fingerprint | A A A D c e B w M A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A G g A A C A A A D g C g g A I C A A A A A g A A A A A A A A A A A A A A A A A A A A A A A A A A E A I A A A A A Q A A F A A A A A A G A w A A P A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 40.5 |
Monoisotopic Mass | 160.146 |
Exact Mass | 160.146 |
XLogP3 | None |
XLogP3-AA | 1.8 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 11 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.9272 |
Human Intestinal Absorption | HIA+ | 0.9722 |
Caco-2 Permeability | Caco2+ | 0.6084 |
P-glycoprotein Substrate | Substrate | 0.5101 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9439 |
Non-inhibitor | 0.5438 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8735 |
Distribution | ||
Subcellular localization | Lysosome | 0.7052 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.8474 |
CYP450 2D6 Substrate | Non-substrate | 0.8409 |
CYP450 3A4 Substrate | Non-substrate | 0.6648 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6223 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.7583 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8492 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8410 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9271 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8342 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9394 |
Non-inhibitor | 0.7996 | |
AMES Toxicity | Non AMES toxic | 0.9248 |
Carcinogens | Carcinogens | 0.5000 |
Fish Toxicity | Low FHMT | 0.6142 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9030 |
Honey Bee Toxicity | High HBT | 0.6845 |
Biodegradation | Not ready biodegradable | 0.8030 |
Acute Oral Toxicity | IV | 0.4876 |
Carcinogenicity (Three-class) | Non-required | 0.6510 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -0.8612 | LogS |
Caco-2 Permeability | 0.9918 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 1.5602 | LD50, mol/kg |
Fish Toxicity | 2.6419 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | -0.4957 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Lipids and lipid-like molecules |
Class | Fatty Acyls |
Subclass | Fatty alcohols |
Intermediate Tree Nodes | Not available |
Direct Parent | Fatty alcohols |
Alternative Parents | |
Molecular Framework | Aliphatic acyclic compounds |
Substituents | Fatty alcohol - Organic oxygen compound - Hydrocarbon derivative - Primary alcohol - Organooxygen compound - Alcohol - Aliphatic acyclic compound |
Description | This compound belongs to the class of organic compounds known as fatty alcohols. These are aliphatic alcohols consisting of a chain of a least six carbon atoms. |
From ClassyFire